tiprankstipranks
Sionna Therapeutics, Inc. (SION)
NASDAQ:SION
US Market
Want to see SION full AI Analyst Report?

Sionna Therapeutics, Inc. (SION) Stock Forecast & Price Target

65 Followers
See the Price Targets and Ratings of:

SION Analyst Ratings

Hold
11Ratings
Hold
1 Buy
10 Hold
0 Sell
Based on 11 analysts giving stock ratings to
Sionna
Therapeutics, Inc.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SION Stock 12 Month Forecast

Average Price Target

$15.17
▼(-66.81% Downside)
Based on 11 Wall Street analysts offering 12 month price targets for Sionna Therapeutics, Inc. in the last 3 months. The average price target is $15.17 with a high forecast of $63.00 and a low forecast of $5.00. The average price target represents a -66.81% change from the last price of $45.70.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"4":"$4","19":"$19","34":"$34","49":"$49","64":"$64"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":63,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$63.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":15.166666666666666,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$15.17</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$5.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[4,19,34,49,64],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,47.13,48.35076923076923,49.571538461538466,50.792307692307695,52.01307692307692,53.23384615384616,54.45461538461539,55.675384615384615,56.89615384615385,58.11692307692308,59.33769230769231,60.55846153846154,61.77923076923077,{"y":63,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,47.13,44.671282051282056,42.2125641025641,39.753846153846155,37.29512820512821,34.83641025641026,32.37769230769231,29.91897435897436,27.46025641025641,25.00153846153846,22.542820512820512,20.08410256410256,17.62538461538461,{"y":15.166666666666666,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,47.13,43.88923076923077,40.64846153846154,37.40769230769231,34.16692307692308,30.92615384615385,27.685384615384617,24.444615384615386,21.203846153846154,17.963076923076922,14.722307692307695,11.481538461538463,8.240769230769232,{"y":5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":16.92,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.39,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28.47,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.21,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.96,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.14,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":43.65,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":33.92,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.3,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.15,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":40.9,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":41.64,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":47.13,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$63.00Average Price Target$15.17Lowest Price Target$5.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Freedom Capital Markets Analyst forecast on SION
Freedom Capital Markets
Freedom Capital Markets
$38$5
Hold
-89.06%
Downside
Reiterated
08/11/26
Sionna Therapeutics price target lowered to $5 from $38 at Freedom BrokerSionna Therapeutics price target lowered to $5 from $38 at Freedom Broker
Guggenheim Analyst forecast on SION
Guggenheim
Guggenheim
Hold
Downgraded
08/10/26
Sionna Therapeutics downgraded to Neutral from Buy at GuggenheimSionna Therapeutics downgraded to Neutral from Buy at Guggenheim
JonesTrading
$63
Hold
37.86%
Upside
Downgraded
08/10/26
Analysts Offer Insights on NA Companies: Sunlight Real Estate Investment (Other OTC: SHTRF) and Sionna Therapeutics, Inc. (NASDAQ: SION)
Citizens JMP Analyst forecast on SION
Citizens JMP
Citizens JMP
Hold
Downgraded
08/10/26
Sionna Therapeutics downgraded to Market Perform from Outperform at CitizensSionna Therapeutics downgraded to Market Perform from Outperform at Citizens
RBC Capital Analyst forecast on SION
RBC Capital
RBC Capital
$23$5
Hold
-89.06%
Downside
Upgraded
08/10/26
Sionna Therapeutics upgraded to Sector Perform from Underperform at RBC CapitalSionna Therapeutics upgraded to Sector Perform from Underperform at RBC Capital
Stifel Nicolaus Analyst forecast on SION
Stifel Nicolaus
Stifel Nicolaus
$55$7
Hold
-84.68%
Downside
Downgraded
08/10/26
Sionna Therapeutics downgraded to Hold from Buy at StifelSionna Therapeutics downgraded to Hold from Buy at Stifel
Wedbush
$5
Hold
-89.06%
Downside
Downgraded
08/10/26
Sionna Therapeutics downgraded to Neutral from Outperform at WedbushSionna Therapeutics downgraded to Neutral from Outperform at Wedbush
BTIG
Hold
Downgraded
08/10/26
Sionna Therapeutics downgraded to Neutral from Buy at BTIGSionna Therapeutics downgraded to Neutral from Buy at BTIG
Raymond James Analyst forecast on SION
Raymond James
Raymond James
Hold
Downgraded
08/10/26
Sionna Therapeutics downgraded to Market Perform from Strong Buy at Raymond JamesSionna Therapeutics downgraded to Market Perform from Strong Buy at Raymond James
LifeSci Capital Analyst forecast on SION
LifeSci Capital
LifeSci Capital
$60$6
Hold
-86.87%
Downside
Downgraded
08/10/26
Sionna Therapeutics: Hold Rating Maintained as Disappointing CF Data Drive Price Target Cut from $60 to $6
TD Cowen Analyst forecast on SION
TD Cowen
TD Cowen
Buy
Reiterated
07/17/26
Sionna Therapeutics, Inc. (SION) Receives a Rating Update from a Top Analyst
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Freedom Capital Markets Analyst forecast on SION
Freedom Capital Markets
Freedom Capital Markets
$38$5
Hold
-89.06%
Downside
Reiterated
08/11/26
Sionna Therapeutics price target lowered to $5 from $38 at Freedom BrokerSionna Therapeutics price target lowered to $5 from $38 at Freedom Broker
Guggenheim Analyst forecast on SION
Guggenheim
Guggenheim
Hold
Downgraded
08/10/26
Sionna Therapeutics downgraded to Neutral from Buy at GuggenheimSionna Therapeutics downgraded to Neutral from Buy at Guggenheim
JonesTrading
$63
Hold
37.86%
Upside
Downgraded
08/10/26
Analysts Offer Insights on NA Companies: Sunlight Real Estate Investment (Other OTC: SHTRF) and Sionna Therapeutics, Inc. (NASDAQ: SION)
Citizens JMP Analyst forecast on SION
Citizens JMP
Citizens JMP
Hold
Downgraded
08/10/26
Sionna Therapeutics downgraded to Market Perform from Outperform at CitizensSionna Therapeutics downgraded to Market Perform from Outperform at Citizens
RBC Capital Analyst forecast on SION
RBC Capital
RBC Capital
$23$5
Hold
-89.06%
Downside
Upgraded
08/10/26
Sionna Therapeutics upgraded to Sector Perform from Underperform at RBC CapitalSionna Therapeutics upgraded to Sector Perform from Underperform at RBC Capital
Stifel Nicolaus Analyst forecast on SION
Stifel Nicolaus
Stifel Nicolaus
$55$7
Hold
-84.68%
Downside
Downgraded
08/10/26
Sionna Therapeutics downgraded to Hold from Buy at StifelSionna Therapeutics downgraded to Hold from Buy at Stifel
Wedbush
$5
Hold
-89.06%
Downside
Downgraded
08/10/26
Sionna Therapeutics downgraded to Neutral from Outperform at WedbushSionna Therapeutics downgraded to Neutral from Outperform at Wedbush
BTIG
Hold
Downgraded
08/10/26
Sionna Therapeutics downgraded to Neutral from Buy at BTIGSionna Therapeutics downgraded to Neutral from Buy at BTIG
Raymond James Analyst forecast on SION
Raymond James
Raymond James
Hold
Downgraded
08/10/26
Sionna Therapeutics downgraded to Market Perform from Strong Buy at Raymond JamesSionna Therapeutics downgraded to Market Perform from Strong Buy at Raymond James
LifeSci Capital Analyst forecast on SION
LifeSci Capital
LifeSci Capital
$60$6
Hold
-86.87%
Downside
Downgraded
08/10/26
Sionna Therapeutics: Hold Rating Maintained as Disappointing CF Data Drive Price Target Cut from $60 to $6
TD Cowen Analyst forecast on SION
TD Cowen
TD Cowen
Buy
Reiterated
07/17/26
Sionna Therapeutics, Inc. (SION) Receives a Rating Update from a Top Analyst
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Sionna Therapeutics, Inc.

3 Months
Ritu BaralTD Cowen
Success Rate
6/8 ratings generated profit
75%
Average Return
+7.54%
Copying Ritu Baral's trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +7.54% per trade.
1 Year
Ritu BaralTD Cowen
Success Rate
3/8 ratings generated profit
38%
Average Return
+29.34%
Copying Ritu Baral's trades and holding each position for 1 Year would result in 37.50% of your transactions generating a profit, with an average return of +29.34% per trade.
2 Years
Ritu BaralTD Cowen
Success Rate
0/8 ratings generated profit
0%
Average Return
-74.78%
Copying Ritu Baral's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -74.78% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SION Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
7
5
4
3
3
Buy
5
15
14
16
7
Hold
0
1
1
1
10
Sell
1
2
1
1
0
Strong Sell
0
0
0
0
1
total
13
23
20
21
21
In the current month, SION has received 10 Buy Ratings, 10 Hold Ratings, and 1 Sell Ratings. SION average Analyst price target in the past 3 months is 15.17.
Each month's total comprises the sum of three months' worth of ratings.

SION Financial Forecast

SION Earnings Forecast

Next quarter’s earnings estimate for SION is -$0.64 with a range of -$0.86 to -$0.36. The previous quarter’s EPS was -$0.66. SION beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year SION has Performed in-line its overall industry.
Next quarter’s earnings estimate for SION is -$0.64 with a range of -$0.86 to -$0.36. The previous quarter’s EPS was -$0.66. SION beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year SION has Performed in-line its overall industry.
No data currently available

SION Sales Forecast

Next quarter’s sales forecast for SION is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. SION beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year SION has Performed in-line its overall industry.
Next quarter’s sales forecast for SION is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. SION beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year SION has Performed in-line its overall industry.

SION Stock Forecast FAQ

What is SION’s average 12-month price target, according to analysts?
Based on analyst ratings, Sionna Therapeutics, Inc.’s 12-month average price target is 15.17.
    What is SION’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for SION, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is SION a Buy, Sell or Hold?
        Sionna Therapeutics, Inc. has a consensus rating of Hold which is based on 1 buy ratings, 10 hold ratings and 0 sell ratings.
          What is Sionna Therapeutics, Inc.’s price target?
          The average price target for Sionna Therapeutics, Inc. is 15.17. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is $63.00 ,the lowest forecast is $5.00. The average price target represents -66.81% Decrease from the current price of $45.7.
            What do analysts say about Sionna Therapeutics, Inc.?
            Sionna Therapeutics, Inc.’s analyst rating consensus is a Hold. This is based on the ratings of 11 Wall Streets Analysts.
              How can I buy shares of SION?
              Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.